definiens: means revenue recognized andrecorded in the books and records of Buyer or Surviving Corporation, as the casemay be ( provided, however, that no such revenue that is recorded on the booksand records of both Buyer and Surviving Corporation shall be counted twice),prepared in accordance with GAAP, for the relevant Milestone period, which, ineach case, is attributable to : ( i ) contract screening services ; ( ii ) providingaccess to information databases to the extent that such services originate fromor are performed by the Company or the Surviving Corporation ; ( iii ) servicesbased on information databases to the extent that such services originate fromor are performed by the Company or the Surviving Corporation ; ( iv ) governmentresearch contracts to the extent that they originate from or are performed bythe Company or the Surviving Corporation ; ( v ) collaborations or research or drugdiscovery or development services performed for third parties or otherwise inconnection with drug discovery or development projects, to the extent that anysuch collaborations, research, drug discovery or development services originatefrom or are performed by the Company or the Surviving Corporation ; ( vi)licensing or other income derived from Company Intellectual Property orIntellectual Property of the Surviving Corporation ; ( vii ) government researchgrants to the extent that they originate from or are performed by the Company orthe Surviving Corporation ; ( viii ) consumable reagents to the extent that theyare developed or produced by the Company or the Surviving Corporation ; and ( ix)assay development services ( provided, however, that solely with respect to the2005 Milestone, only assay development services actually performed by theCompany or the Surviving Corporation or originated by the Company or theSurviving Corporation shall count towards the calculation of Milestone Revenue;and provided further, however, that with respect to the assay developmentservices described in clauses ( A ) and ( B ) of Section 1.9(d)(ii ), only to theextent such assay development services are actually performed by the SurvivingCorporation shall such assay development services count towards the calculationof Milestone Revenue for any Milestone period ) . Such definition shall excludeall other Buyer revenue, including, but not limited to, any revenue from thesale by Buyer of instruments or related consumables ( such as LabChip devices, datapoints or reagents, except to the extent that such devices, datapoints orreagents originate from or are developed or produced by the Company or theSurviving Corporation ), and any revenue from the sale of 9 < PAGE > instrument servicing contracts . The calculation of Milestone Revenue shall alsoexclude revenue adjustments resulting from a change in the SurvivingCorporation 's or Buyer 's accounting methods, principles or practices from thoseof the Company, as consistently applied over prior periods, or a change in GAAPor any GAAP election or treatment not made or utilized by the Company in itsaudited financial statements for its fiscal year ended December 31, 2004